GoodRx expects Pharma Direct revenue growth of at least 30% in 2026 amid shift to pharma manufacturer solutions
GoodRx Holdings, Inc. Class A Common Stock · SERVICES-COMPUTER PROCESSING & DATA PREPARATION · Now $3.08
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS